Thursday, April 23, 2026 – Friday, April 24 - (MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics.
Many patients taking glucagon-like peptide-1 (GLP-1) receptor agonists...
Thursday, April 23, 2026 – Friday, April 24 - An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid regaining the pounds they shed, according to a study presented at Digestive Disease Week (DDW) 2026.
Thursday, April 23, 2026 – Friday. April 24 - Bagsværd, Denmark, – Novo Nordisk today announced positive topline results from PIONEER TEENS, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years with type 2...
Thursday, April 23, 2026 – Thursday, April 23 - Roche and Zealand Pharma announced last month that their amylin analog petrelintide elicited a 9% placebo-controlled weight reduction at 42 weeks—falling far below analyst and investor expectations.
Thursday, April 23, 2026 – Thursday, April 23 - A new minimally invasive procedure may help people keep weight off after stopping popular drugs like Ozempic and semaglutide—something most patients struggle with. In a clinical trial, those who underwent a technique called duodenal mucosal resurfacing regained far less weight compared to others after discontinuing the medication. The procedure works by renewing the lining of the upper small intestine, potentially “resetting” metabolism and preserving the benefits of weight loss.
Wednesday, April 22, 2026 – Thursday, April 23 - New Life told FDA inspectors that they lacked the authority to enter parts of a facility where it made the GLP-1 receptor agonists semaglutide and tirzepatide.
Wednesday, April 22, 2026 – Thursday, April 23 - Outspoken body acceptance advocate Katie Sturino, who is the founder of Megababe Beauty, explains why it was a difficult decision for her to start taking weight loss drugs. She's joined by psychiatrist Dr. Sue Varma who breaks down what people should do before taking a GLP-1 and the impact of societal pressure.
Wednesday, April 22, 2026 – Thursday, April 23 - Two of the biggest insurance providers have expressed reluctance to participate in the government’s BALANCE program that would have made GLP-1 drugs more affordable to patients.
Wednesday, April 22, 2026 – Thursday, April 23 - Amazon announced plans to sell the most popular GLP-1 weight loss medications and even offer same-day delivery in the United States. NBC’s Brian Cheung joins TODAY to break down what customers need to know, including whether it will save you money.
Tuesday, April 21, 2026 – Wednesday, April 22 - (MedPage Today) -- A small trial suggested that timing exercise to match body clock chronotype enhanced cardiometabolic and sleep-related outcomes. (Open Heart)
The Society of Thoracic Surgeons published its new guideline for preventing and treating...